Terms: = Breast cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC AND Clinical Outcome
2 results:
1. Association of xpc polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (xpc) expression in sporadic breast cancer patients.
Bai X; Jin F; Fu Y; Yu Z; Zhao L; Ren J; Li Y; Jiao X; Zhao H; Yao W; Mi X; Wang E; Olopade OI; Zhou M; Wei M
Med Oncol; 2012 Sep; 29(3):1543-53. PubMed ID: 22038723
[TBL] [Abstract] [Full Text] [Related]
